Skip to main content
SpringerLink
Log in

Fluvoxamin: Ausblick auf neue Indikationen

  • Conference paper
Phantasie und Wirklichkeit — Fluvoxamin

  • 25 Accesses

Zusammenfassung

Der Begriff Indikation wird in der Medizin allgemein als zwingender Grund verstanden, ein bestimmtes diagnostisches und/oder therapeutisches Verfahren in einem bestimmten Krankheitsfall anzuwenden. In der Pharmakotherapie hat der Begriff Indikation eine erweiterte Bedeutung: Er meint hier Anwendungsgebiet für ein bestimmtes Pharmakon oder eine bestimmte Gruppe von Pharmaka.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Amin MM, Anath JV, Coleman BS, Darcourt G, Farkes T, Goldstein B et al. (1984) Fluvoxamine: antidepressant effects confirmed in a plabeco-controlled international study. Clin Neuropharmacol 7/1:580–581

    Google Scholar 

  • Brunello N, Chuang DM, Costa E (1982) Different synaptic location of mianserin and imipramine binding sites. Science 215:1112–1114

    Article  PubMed  CAS  Google Scholar 

  • Brunello N, Riva M, Volterra A, Racagni G (1986) Biochemical changes in rat brain after acute and chronic administration of fluvoxamine, a selective 5-HT uptake blocker: comparison with desmethylimipramine. Adv Pharmakother 2:189–196

    Google Scholar 

  • Carasso RL (1979) Clomipramine and amitriptyline in the treatment of severe pain. Int J Neurosci 9:191–194

    Article  PubMed  CAS  Google Scholar 

  • Claassen V (1983) Review of the animal pharmacology and pharmacokinetics of fluvoxamine. Br J Clin Pharmacol 15 (Suppl 3):349–355

    CAS  Google Scholar 

  • Claassen V, Davies JE, Hertting G, Placheta P (1977) Fluvoxamine, a specific 5- hydroxytryptamine uptake inhibitor. Br J Pharmacol 60:505–516

    PubMed  CAS  Google Scholar 

  • De Bree H, Van der Schoot JB, Post LC (1983) Fluvoxamine maleate; disposition in man. Eur Jr Drug Metab Pharmacokinet 8:175–179

    Article  Google Scholar 

  • Dehen H, Wilier JC, Amsallem B, Perdrisot R (1984) Indalpine and analgesis. Adv Biol Psychiatry 14:46–53

    Google Scholar 

  • Den Boer JA, Westenberg HGM (1988 a) Effect of a serotonin and noradrenalin uptake inhibitor in panic disorder; a double-blind comparative study with fluvoxamine and maprotiline. Int Clin Psychopharmacol 3:59–74

    Article  Google Scholar 

  • Den Boer JA, Westenberg HGM (1988 b) Serotonin function in panic disorder; A double-blind placebo-controlled study of fluvoxamine and ritanserin. In: Westenberg HGM. Den Boer JA (1988) Klinische und biochemische Wirkung selektiver Serotonin-Wiederaufnahmehemmer bei Angststörungen. Adv Biol Psychiatry 17:1–19

    Google Scholar 

  • Den Boer JA, Westenberg HGM, Kamerbeek WDJ, Verhoeven WMA, Kahn RS (1987) Effect of serotonin uptake inhibitors in Anxiety disorders: a double-blind comparison of clomipramine and fluvoxamine. Int Clin Psychopharmacol 2:21–32

    Article  Google Scholar 

  • De Wilde JEM, Doogan DP (1982) Fluvoxamine and chlorimipramine in endogenous depression. J Affective Disord 4:249–259

    Article  Google Scholar 

  • Dick P, Ferrero EA (1983) A double-blind comparative study of the clinical efficacy of fluvoxamine and chlorimipramine. Br J Clin Pharmacol 15 (Suppl 3):419–426

    Google Scholar 

  • Dresse A, Scuvee-Moreau J (1984) The effects of various antidepressants on the spontaneous firing rates of noradrenergic and serotonergis neurones. Clin Neuropharmacol 7 (Suppl 1): 572–573

    Google Scholar 

  • Evans L, Kenardy J, Schneider P, Hoey H (1986) Effect of a selective serotonin uptake inhibitor in agoraphobia with panic attacks; a doubleblind comparison of zimelidine, imipramine and placebo. Acta Psychiatr Scand 73:49–53

    Article  PubMed  CAS  Google Scholar 

  • Feinmann C (1985) Pain relief by antidepressants: possible modes of action. Pain 23:1–8

    Article  PubMed  CAS  Google Scholar 

  • Fichter MM, Goebel G (1991) Anorexia und Bulimia nervosa: Symptomatik, medizinische Komplikationen, Äthiologie und Behandlung, Internist 32:38–49

    PubMed  CAS  Google Scholar 

  • Goodmann WK, Price LH, Charney DS (1989 a) Fluvoxamine in obsessive-compulsive disorder. Psychiatr Ann 19/2:92–96

    Google Scholar 

  • Goodman WK, Price LH, Delgado PL, Palumbo J, Krystal JH, Nagy LM, Rasmussen SA, Heninger JR, Charney DS (1990) Specificity of serotonin reuptake inhibitor in the treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 47:577–585

    Article  PubMed  CAS  Google Scholar 

  • Goodman WK, Price LH, Rasmussen SA, Delgado PL, Heninger GR, Charney DS (1989 b) Efficacy of fluvoxamine in obsessive compulsive disorder. Arch Gen Psychiatry 46:46–44

    Google Scholar 

  • Halla R (1989) Die Pharmakotherapie der Panikerkrankung - Eine Übersicht. TW Neurologie Psychiatrie (Sonderheft, Dezember): 39–46

    Google Scholar 

  • Hammond DL, Tyce GM, Yaksh TL (1985) Efflux of 5-hydroxytryptamine and noradrenaline into spinal cord superfusates during stimulation of the rat medulla. J Physiol 359:151–162

    PubMed  CAS  Google Scholar 

  • Jurna I (1983) Analgetika. In: Forth W, Henschler D, Rummel W (Hrsg) Allgemeine und spezielle Pharmakologie und Toxikologie, 4. Aufl. Bibliographisches Institut, Mannheim Wien Zürich

    Google Scholar 

  • Kahn RS, Van Praag HM, Wetzler S, Asnis GM, Barr G (1988) Serotonin and anxiety revisited. Biol Psychiatry 23:189–208

    Article  PubMed  CAS  Google Scholar 

  • Kahn RS, Westenberg HGM, Verhoeven WMA, Gispen-De Wied OC, Kamerbeek WDJ (1987) Effect of a serotonin precursor and uptake inhibitor in anxiety disorders: a double-blind comparison of 5-Hydroxytryptophan, clomipramine and placebo. Int Clin Psychopharmacol 2:33–45

    Article  PubMed  CAS  Google Scholar 

  • Kasper S, Voll G, Vieira A, Kick H (1990) Response to total sleep deprivation before and during treatment with fluvoxamine or maprotiline in patients with major depression - results of a double-blind study. Pharmacopsychiatry 23:135–142

    Article  PubMed  CAS  Google Scholar 

  • Klok CJ, Brouwer GJ, van Praag HM, Doogan D (1981) Fluvoxamine and clomipramine in depressed patients. A double-blind clinical study. Acta Psychiatr Scand 64:1–11

    Article  PubMed  CAS  Google Scholar 

  • Krijzer HF, Snelder M, Bradford D (1984) Comparison of the proconvulsive properties of fluvoxamine and clovoxamine with eight other antidepressants in an animal model. Neuropsychobiology 12:249–254

    Article  PubMed  CAS  Google Scholar 

  • Langer SZ, Moret C, Raisman R, Dubocowich ML, Briley H (1980) High affinity 3H-imipramine binding on rat hypothalamus: association with uptake of serotonin but not of norepinephrine. Science 210:1133–1135

    Article  PubMed  CAS  Google Scholar 

  • Lapierre YD, Rastogi RB, Singhal RL (1983) Fluvoxamine influences serotonergic system in the brain: neurochemical evidence. Neuropsychobiology 10:213–216

    Article  PubMed  CAS  Google Scholar 

  • Maj J, Rogoz Z, Skuza G (1982) Fluvoxamine, a new antidepressant drug fails to show antiserotonin activity. Eur J Pharmacol 81:287–292

    Article  PubMed  CAS  Google Scholar 

  • Mavissakalian M, Perel J, Bowler K, Dealy R (1987). Trazodone in the treatment of panic disorder and agoraphobia with panic attacks. Am J Psychiatry 144:785–787

    PubMed  CAS  Google Scholar 

  • Oliver B, Mos J, Schipper J (1986) Serotonin and aggressive behaviour in the rat. Psychopharmacology 89:26

    Google Scholar 

  • Overmars H, Scherpenisse PM, Post LC (1983) Fluvoxamine maleate: metabolism in man. Eur J Drug Metab Pharmacokinet 8:269–280

    Article  PubMed  CAS  Google Scholar 

  • Paoli F, Farcourt G, Cossa P (1960) Note preliminairs sur l’action de l’imipramine dans les etats doloureux. Rev Neurol 102:503–504

    PubMed  CAS  Google Scholar 

  • Perse T (1988) Obsessive-compulsive disorder: A treatment overview. J Clin Psychiatry 49:48–55

    PubMed  CAS  Google Scholar 

  • Rost W, Schmidtke A, Hübner C, Bauer K, Gattaz WF (1988) A comparison of the onset of action between maprotiline and fluvoxamine. Psychopharmacology (Suppl) 96:145

    Google Scholar 

  • Sheehan DV, Zak JP, Miller JA, Fanous BSL (1988) Panic disorder: The potential role of serotonin reuptake inhibitors. J Clin Psychiatry 49:30–36

    PubMed  Google Scholar 

  • Wagner W, Wakelin JS, Coleman B, Cimander K (1985) Therapeutische Ergebnis- se mit Fluvoxamin und der Einfluβ psychotroper Begleitmedikation auf Wirk- samkeit und Verträglichkeit. Eine internationale kontrollierte Doppelblindstu- die mit 464 depressiven Patienten. Adv Pharmacother 2:33–65

    Google Scholar 

  • Watkins LR, Johannessen JN, Kinschek IB, Mayer DJ (1984) The neurochemical basis of footshock analgesia: the role of spinal cord serotonin and norepinephrine. Brain Res 290:107–117

    Article  PubMed  CAS  Google Scholar 

  • Wittchen HU, Saβ H, Zaudig M, Koehler K (1989) Diagnostisches und statisti- sches Manual psychischer Störungen DSM-III R (Revision). Beltz, Weinheim Basel

    Google Scholar 

  • Yaksh TL, Wilson PR (1979) Spinal serotonin system mediates antinociception. J Pharmacol Exp Ther 208:446–453

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Robert Halla
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Psychiatrischen Klinik und Poliklinik, Universität München, Nußbaumstraße 7, D-8000, München 2, Germany

    Hanns Hippius (Direktor) (Direktor)

  2. Psychiatrischen Universitätsklinik, Wilhelm-Klein-Straße 27, CH-4025, Basel, Switzerland

    Walter Pöldinger (Ärztlicher Direktor) (Ärztlicher Direktor)

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Halla, R. (1991). Fluvoxamin: Ausblick auf neue Indikationen. In: Hippius, H., Pöldinger, W. (eds) Phantasie und Wirklichkeit — Fluvoxamin. Die Reihe duphar med communication wird herausgegeben von Wolfgang Wagner und Ulrike Evers, Hannover.. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76935-1_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76935-1_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-54551-4

  • Online ISBN: 978-3-642-76935-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation